139 related articles for article (PubMed ID: 15791775)
1. Individualized Pharmacotherapy Utilizing Genetic Biomarkers and Novel In Vitro Systems As Predictive Tools for Optimal Drug Development and Treatment.
Ingelman-Sundberg M; Lauschke VM
Drug Metab Dispos; 2024 May; 52(6):467-475. PubMed ID: 38575185
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics and adverse effects of anti-infective drugs in children.
Huang X; Hu B; Ye L; Li T; He L; Tan W; Yang G; Liu JP; Guo C
Clin Exp Pharmacol Physiol; 2024 Jan; 51(1):3-9. PubMed ID: 37840030
[TBL] [Abstract][Full Text] [Related]
3. PG-path: Modeling and personalizing pharmacogenomics-based pathways.
Hong JY; Kim JH
PLoS One; 2020; 15(5):e0230950. PubMed ID: 32365122
[TBL] [Abstract][Full Text] [Related]
4. Identifying genomic and developmental causes of adverse drug reactions in children.
Becker ML; Leeder JS
Pharmacogenomics; 2010 Nov; 11(11):1591-602. PubMed ID: 21121777
[TBL] [Abstract][Full Text] [Related]
5. Genomic architecture of pharmacological efficacy and adverse events.
Chhibber A; Kroetz DL; Tantisira KG; McGeachie M; Cheng C; Plenge R; Stahl E; Sadee W; Ritchie MD; Pendergrass SA
Pharmacogenomics; 2014 Dec; 15(16):2025-48. PubMed ID: 25521360
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics and adverse drug reactions in children.
Rieder MJ; Carleton B
Front Genet; 2014; 5():78. PubMed ID: 24795743
[TBL] [Abstract][Full Text] [Related]
7. Editorial: The impact of the human genome on interindividual variability in drug response.
Kassogue Y; Fricke-Galindo I
Front Genet; 2024; 15():1401604. PubMed ID: 38711917
[No Abstract] [Full Text] [Related]
8. Pharmacogenomics: Medical Advancement Caught in an Ethical and Policy Quagmire.
Davitian L
Sr Care Pharm; 2024 Apr; 39(4):159-162. PubMed ID: 38528334
[No Abstract] [Full Text] [Related]
9. Pharmacogenomics and drug therapy.
Goh S
Aust Prescr; 2018 Feb; 41(1):6. PubMed ID: 29507452
[No Abstract] [Full Text] [Related]
10. Pharmacogenomics: bridging the gap between science and practice.
Lee KC; Ma JD; Kuo GM
J Am Pharm Assoc (2003); 2010; 50(1):e1-14; quiz e15-7. PubMed ID: 20368146
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacogenomics and the path towards personalized medicine].
Belloso WH; Redal MA
Medicina (B Aires); 2010; 70(3):265-74. PubMed ID: 20529779
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics: the promise of personalized medicine.
Mancinelli L; Cronin M; Sadée W
AAPS PharmSci; 2000; 2(1):E4. PubMed ID: 11741220
[TBL] [Abstract][Full Text] [Related]
13. [Drug therapy and pharmacogenomics--hopes and facts].
Müller-Zellenberg U; Müller M
Wien Med Wochenschr; 2005 Feb; 155(3-4):45-9. PubMed ID: 15791775
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics: translating functional genomics into rational therapeutics.
Evans WE; Relling MV
Science; 1999 Oct; 286(5439):487-91. PubMed ID: 10521338
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics and drug response.
Müller M
Int J Clin Pharmacol Ther; 2003 Jun; 41(6):231-40. PubMed ID: 12816175
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
